GKIM
MEDP icon

GW&K Investment Management’s Medpace MEDP Stock Holding History

GW&K Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$91.5M Sell
172,696
-10,076
-6% -$4.65M 0.71% 28
2026
Q1 		$87.8M Buy
182,772
+26,574
+17% +$13.6M 0.77% 27
2025
Q4 		$87.7M Sell
156,198
-42,063
-21% -$23.9M 0.76% 20
2025
Q3 		$102M Sell
198,261
-61,442
-24% -$26.8M 0.9% 16
2025
Q2 		$81.5M Sell
259,703
-11,053
-4% -$3.32M 0.73% 19
2025
Q1 		$82.5M Sell
270,756
-4,704
-2% -$1.58M 0.76% 22
2024
Q4 		$91.5M Buy
275,460
+133,379
+94% +$45.2M 0.78% 18
2024
Q3 		$47.4M Sell
142,081
-29,445
-17% -$11.2M 0.41% 93
2024
Q2 		$70.6M Sell
171,526
-1,195
-0.7% -$473K 0.65% 34
2024
Q1 		$69.8M Sell
172,721
-47,647
-22% -$16.8M 0.62% 38
2023
Q4 		$67.5M Sell
220,368
-12,439
-5% -$3.36M 0.63% 39
2023
Q3 		$56.4M Sell
232,807
-17,960
-7% -$4.59M 0.57% 57
2023
Q2 		$60.2M Sell
250,767
-2,669
-1% -$554K 0.57% 51
2023
Q1 		$47.7M Buy
253,436
+616
+0.2% +$127K 0.46% 91
2022
Q4 		$53.7M Sell
252,820
-2,022
-0.8% -$404K 0.54% 63
2022
Q3 		$40.1M Sell
254,842
-93,578
-27% -$14.9M 0.44% 94
2022
Q2 		$52.1M Buy
348,420
+18,274
+6% +$2.65M 0.56% 56
2022
Q1 		$54M Sell
330,146
-4,823
-1% -$795K 0.48% 78
2021
Q4 		$72.9M Sell
334,969
-58,654
-15% -$12.3M 0.61% 44
2021
Q3 		$74.5M Sell
393,623
-1,560
-0.4% -$285K 0.67% 35
2021
Q2 		$69.8M Buy
395,183
+44,560
+13% +$7.69M 0.61% 45
2021
Q1 		$57.5M Buy
350,623
+34,780
+11% +$5.32M 0.53% 60
2020
Q4 		$44M Buy
+315,843
New +$39.8M 0.46% 72

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GW&K Investment Management's MEDP Position: Q2 2026 in Review

GW&K Investment Management reduced its Medpace (MEDP) stake by 5.5% in Q2 2026, selling an estimated $4.65M and leaving 172,696 shares worth $91.5M. The position accounts for 0.71% of the portfolio, ranked #28.

GW&K Investment Management first reported a position in MEDP in Q4 2020 and has held it in 23 quarters since. The position peaked at $102M in Q3 2025. 694 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • GW&K Investment Management held 172,696 shares of Medpace worth $91.5M as of Q2 2026.
  • GW&K Investment Management sold 10,076 Medpace shares in Q2 2026, an estimated $4.65M.
  • Medpace made up 0.71% of GW&K Investment Management's portfolio in Q2 2026, its #28 holding.
  • GW&K Investment Management first reported a position in Medpace in Q4 2020 and has held it in 23 quarters since.
  • GW&K Investment Management's Medpace position peaked at $102M in Q3 2025.
  • 694 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on GW&K Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.